Mobile Imaging Services Market: Market Size & Forecast 2026

Mobile imaging services cover the full spectrum of diagnostic imaging delivered outside the confines of a traditional radiology department, whether through mobile vehicles, portable bedside equipment, or freestanding ambulatory facilities. The broader diagnostic imaging market, of which mobile and point-of-care services are a meaningful and growing component, is valued at roughly $160 billion and expanding at a steady mid-single-digit pace. Service providers span a wide continuum, from large integrated delivery networks that operate their own imaging fleets to independent specialty operators focused exclusively on mobile or point-of-care modalities.

• •The overall diagnostic imaging services market reached approximately $151-160 billion in recent years, with the mobile segment representing a significant and fast-growing portion
• •Core service modalities include X-ray, ultrasound, MRI, and CT scanning, with mobile X-ray and ultrasound commanding the largest share of mobile deployments
• •End-users span hospitals and ambulatory surgical centers, specialty clinics, long-term care facilities, and direct-to-consumer settings

A combination of epidemiological trends and healthcare system dynamics is propelling demand. Rising incidence of oncological, cardiovascular, and musculoskeletal conditions increases the volume of imaging encounters required across care pathways. At the same time, healthcare systems face mounting pressure to reduce costs, shorten length of stay, and improve access in underserved or rural areas, objectives that mobile imaging directly addresses.

• •Aging populations and associated growth in chronic disease burden are driving higher per-capita demand for diagnostic imaging across all modalities
• •Cost-efficiency pressures favor mobile and point-of-care models that eliminate patient transport, reduce facility overhead, and increase equipment utilization rates
• •Technological miniaturization of imaging devices, particularly handheld and bedside ultrasound, is expanding the range of clinical settings where imaging can be performed on-site

By service type, the market breaks down across X-ray, ultrasound, MRI, CT, and other modalities, with X-ray and ultrasound representing the largest shares due to their breadth of clinical application and relatively lower capital barriers to deployment. By application, oncology, cardiology, orthopedics, and gynecology are the dominant referral specialties. North America commands the largest regional share, supported by advanced healthcare infrastructure, favorable reimbursement frameworks, and high adoption of mobile imaging solutions; significant growth is also observed in parts of Asia-Pacific as healthcare access expands.

• •North America leads in market value, driven by well-developed hospital networks and widespread teleradiology adoption enabling remote interpretation of mobile-captured images
• •Ultrasound and X-ray dominate the modality breakdown, while MRI and CT, though smaller in volume, command higher per-scan pricing and are increasingly offered via mobile units
• •The Asia-Pacific region is projected as the fastest-growing geographic segment, with expanding hospital construction and growing demand for accessible imaging in densely populated and underserved markets

Who are the notable companies in the industry?

The mobile imaging services market exhibits a fragmented competitive structure, with no single entity commanding dominant global share. The competitive field divides broadly into integrated operators, large hospital systems or multi-specialty providers operating proprietary imaging fleets, and standalone specialty imaging operators that focus exclusively on mobile and ambulatory services. Front Range Mobile Imaging and DMS Health Technologies exemplify the former, leveraging cross-service synergies across broader healthcare networks, while Akumin Inc and Accurate Imaging Inc illustrate the specialty model, concentrating capacity on contractual arrangements with hospital partners and physician groups. Cobalt Imaging Center similarly occupies this niche, as does RadNet, Inc., which has scaled through strategic consolidation. Photonis and Telops differentiate through advanced sensor and infrared imaging technology rather than clinical service delivery. Capacity remains concentrated in North America and Western Europe, where reimbursement structures and healthcare density sustain commercial viability, though operator footprints are gradually expanding into emerging markets as outsourced imaging demand grows.

• •The market is moderately fragmented, with competition occurring across tiers: large national hospital systems, regional mobile imaging networks, and independent specialty operators, each serving overlapping but differentiated patient populations
• •Technology and process routes center on the deployment of standard diagnostic imaging equipment, X-ray, ultrasound, MRI, and CT, on mobile vehicle platforms or as portable devices, supported by cloud-based PACS infrastructure and teleradiology networks for interpretation
• •Regional capacity concentration is highest in North America, with notable deployments across Western Europe and select Asia-Pacific markets; emerging markets remain relatively underpenetrated due to infrastructure and capital constraints

What are the recent trends and outlook?

Artificial intelligence is emerging as one of the most consequential trends reshaping the market, with AI-assisted image acquisition and interpretation tools enhancing throughput, reducing radiologist workload, and improving diagnostic accuracy. Concurrently, the consolidation of imaging capacity among larger operators is expected to continue as providers seek scale to justify equipment investment and manage regulatory complexity. Over the forecast horizon, the convergence of portable device technology, AI integration, and evolving value-based care models should sustain the market's steady growth trajectory while gradually shifting the mix toward more distributed, point-of-care imaging.

• •AI integration into imaging workflows is projected to become a significant competitive differentiator, with the AI-in-medical-imaging market on a trajectory to exceed $22 billion in the near term
• •Ongoing consolidation activity is likely as mid-size specialty operators seek scale advantages in equipment procurement, technology licensing, and compliance management
• •Value-based care reimbursement models are incentivizing providers to demonstrate faster turnaround times and improved clinical outcomes, supporting investment in mobile imaging infrastructure and digital workflow tools